Key statistics
As of last trade, Evolus Inc (0K16:LSE) traded at 12.59, 58.96% above the 52 week low of 7.92 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 12.59 |
Low | 12.59 |
Bid | -- |
Offer | -- |
Previous close | 12.59 |
Average volume | 1.17k |
---|---|
Shares outstanding | 63.32m |
Free float | 49.78m |
P/E (TTM) | -- |
Market cap | 787.72m USD |
EPS (TTM) | -0.9141 USD |
Data delayed at least 20 minutes, as of Nov 12 2024 16:46 GMT.
More ▼
Press releases
- Evolus Reports Third Quarter 2024 Results
- Evolus to Participate in Stifel 2024 Healthcare Conference
- Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
- Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers
- Evolus to Report Third Quarter Financial Results on November 6, 2024
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
More ▼